BCL3 Antikörper (Middle Region)
Kurzübersicht für BCL3 Antikörper (Middle Region) (ABIN950634)
Target
Alle BCL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 248-277, Middle Region
-
Spezifität
- This antibody reacts to Bcl-3.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human and Mouse.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 248~277 amino acids from the Center region of human BCL3
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Andere Bezeichnung
- Bcl-3
-
Hintergrund
- BCL3 is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers.Synonyms: B-cell lymphoma 3-encoded protein, BCL3, BCL4, D19S37
-
Gen-ID
- 602
-
NCBI Accession
- NP_005169
-
Pathways
- NF-kappaB Signalweg, Maintenance of Protein Location, Protein targeting to Nucleus
Target
-